These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32157797)

  • 21. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Grupo Argentino de Estudio de Placenta Retenida.
    Carroli G; Belizan JM; Grant A; Gonzalez L; Campodonico L; Bergel E
    Br J Obstet Gynaecol; 1998 Feb; 105(2):179-85. PubMed ID: 9501783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2001; (4):CD001337. PubMed ID: 11687109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal timing of misoprostol administration in nulliparous women undergoing office hysteroscopy: a randomized double-blind placebo-controlled study.
    Fouda UM; Gad Allah SH; Elshaer HS
    Fertil Steril; 2016 Jul; 106(1):196-201. PubMed ID: 27037462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misoprostol versus oxytocin for the reduction of postpartum blood loss.
    Baskett TF; Persad VL; Clough HJ; Young DC
    Int J Gynaecol Obstet; 2007 Apr; 97(1):2-5. PubMed ID: 17321529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised placebo controlled trial of oral misoprostol in the third stage of labour.
    Hofmeyr GJ; Nikodem VC; de Jager M; Gelbart BR
    Br J Obstet Gynaecol; 1998 Sep; 105(9):971-5. PubMed ID: 9763047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial.
    Winikoff B; Dabash R; Durocher J; Darwish E; Nguyen TN; León W; Raghavan S; Medhat I; Huynh TK; Barrera G; Blum J
    Lancet; 2010 Jan; 375(9710):210-6. PubMed ID: 20060161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Titrated oral misoprostol solution versus vaginal misoprostol for labor induction.
    Souza AS; Feitosa FE; Costa AA; Pereira AP; Carvalho AS; Paixão RM; Katz L; Amorim MM
    Int J Gynaecol Obstet; 2013 Dec; 123(3):207-12. PubMed ID: 24112746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbetocin versus intra-umbilical oxytocin in the management of retained placenta: a randomized clinical study.
    Elfayomy AK
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1207-13. PubMed ID: 25976063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regarding Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol. 2007;86:48-54.
    van Stralen G; van Roosmalen J
    Acta Obstet Gynecol Scand; 2007; 86(6):764; author reply 765. PubMed ID: 17520415
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial.
    Alalfy M; Lasheen Y; Elshenoufy H; Elzahaby IM; Kaleem HW; El Sawah H; Azkalani A; Saber W; Rashwan ASSA
    J Matern Fetal Neonatal Med; 2020 May; 33(9):1459-1465. PubMed ID: 30176758
    [No Abstract]   [Full Text] [Related]  

  • 32. Rectal administration of misoprostol for the management of retained placenta--a preliminary report.
    Li YT; Yin CS; Chen FM
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Dec; 64(12):721-4. PubMed ID: 11922493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic intervention for the management of retained placenta: a systematic review and meta-analysis of randomized trials.
    Patrick HS; Mitra A; Rosen T; Ananth CV; Schuster M
    Am J Obstet Gynecol; 2020 Sep; 223(3):447.e1-447.e19. PubMed ID: 32592695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomization of two dosing regimens of vaginal misoprostol for cervical ripening and labor induction in a low resource setting.
    Adeniyi AA; Odukogbe AA; Olayemi A; Oladokun O; Adeniji AO; Aimakhu CO; Enakpene C
    Niger J Clin Pract; 2014; 17(3):287-91. PubMed ID: 24714004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage.
    Ozkaya O; Sezik M; Kaya H; Desdicioglu R; Dittrich R
    J Obstet Gynaecol Res; 2005 Oct; 31(5):389-93. PubMed ID: 16176505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal misoprostol vs 15-methyl prostaglandin F2alpha for retained placenta after second-trimester delivery.
    Sundaram S; Diaz JP; González-Quintero VH; Verma U
    Am J Obstet Gynecol; 2009 May; 200(5):e24-6. PubMed ID: 19136084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction.
    Farah LA; Sanchez-Ramos L; Rosa C; Del Valle GO; Gaudier FL; Delke I; Kaunitz AM
    Am J Obstet Gynecol; 1997 Aug; 177(2):364-9; discussion 369-71. PubMed ID: 9290452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
    Denison FC; Carruthers KF; Hudson J; McPherson G; Chua GN; Peace M; Brewin J; Hallowell N; Scotland G; Lawton J; Norrie J; Norman JE;
    PLoS Med; 2019 Dec; 16(12):e1003001. PubMed ID: 31887169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.